Dalibor Jilek

Czech Hizentra Noninterventional Study With Rapid Push: Efficacy, Safety, Tolerability, and Convenience of Therapy With 20% Subcutaneous Immunoglobulin

2019 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové

Publication